Standard of care for pregnant women with an opioid use disorder

[Tile text, Standard of care for pregnant
women with an opioid use disorder] [Dr. Jones speaking]
So, since the Mother Study was published in the 2010, there have been a number of guidelines
that have come out both internationally as well as within the United States. For example, the W-H-O, the World Health Organization
guidelines were published in 2014 and those guidelines clearly state that for women who
have an opioid use disorder while they’re pregnant, there are two medications that are
a standard of care to treat them, methadone or buprenorphine. For the United Nations there are international
standards of drug treatment and in those standards in the section about women and children it
specifically stated that both methadone and buprenorphine are the accepted standard of
care to treat opioid use disorder during pregnancy. As well, the American Society of Addiction
Medicine and the ACOG Organization have also endorsed methadone and buprenorphine acceptable
practices to treat opioid use disorder during pregnancy. [Text Title: Despite the Evolving Guidelines,
Obstacles Remain] So, some of the obstacles to women to be able to receive a medication assisted treatment like methadone and buprenorphine during pregnancy include just sheer non-availability
of those medications in their local communities. Sometimes methadone clinics are hundreds of
miles away from where women live, or sometimes there are not enough buprenorphine waiver
providers that are able to prescribe the medication to women, so access is definitely a huge driving
barrier for women to receive medication assisted treatment during pregnancy. [End slate with HHS and NIDA logo and website,]

Leave a Reply

Your email address will not be published. Required fields are marked *